Clinicians and patients faced significant disruption in liver cancer screening during the early COVID-19 pandemic, according to survey results reported at the 2021 European Association for the Study of the Liver’s Digital Liver Cancer Summit.
Researchers used the experience of 76 liver cancer treatment centers in Europe, North America, South America, Asia and Africa in their analysis. The study documents the evolution in clinical practice between March and June 2020, during the first wave